Status:
UNKNOWN
Treatment of Febrile Infectious Disease Among Children in Hadera District Given the Final Diagnosis. Descriptive Study
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
Febrile Illness Acute
Eligibility:
All Genders
7-18 years
Brief Summary
Study goal - to describe pediatric patients with febrile disease that administered to the emergency department (ED) of hillel-yaffe hospital, according to arrival diagnosis, ED diagnosis, given therap...
Detailed Description
Major goal: To describe cases that arrived to the pediatric ED with acute febrile illness (up to 7 days of fever) and the final diagnosis they received. To describe the antibiotic treatment given in ...
Eligibility Criteria
Inclusion
- Children aged 7 days to 18 years.
- Body temperature that is higher than 37.5°C (Rectal or Oral).
- Informed consent obtained from parents.
Exclusion
- Children with fever that is longer than 7 days.
- Children diagnosed with immunodeficiency.
- Children that receive chemotherapy.
- Children treated with high dose steroids.
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT02313532
Start Date
January 1 2015
End Date
December 1 2015
Last Update
December 10 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hillel Yaffe MC,
Hadera, Israel